972 filings
Page 4 of 49
4
wdh9tuyni8rmezg
16 Mar 23
Acer Therapeutics / John Michael Klopp ownership change
4:43pm
4
i25m1i
16 Mar 23
Acer Therapeutics / Donald Joseph ownership change
4:41pm
4
bg3 7tromywwc7xd
16 Mar 23
Acer Therapeutics / Tanya Hayden ownership change
4:39pm
4
lmn0xf2
16 Mar 23
Acer Therapeutics / MICHELLE RENEE GRIFFIN ownership change
4:37pm
4
v8xulqnf6fx1t2d
16 Mar 23
Acer Therapeutics / JOHN MICHAEL DUNN ownership change
4:35pm
4
hpehg
16 Mar 23
Acer Therapeutics / Jefferson E Davis ownership change
4:32pm
4
wv87fg86fwso43em8hvs
16 Mar 23
Acer Therapeutics / STEVE ASELAGE ownership change
4:30pm
4
1l81gc 7bopgls0rcnt9
16 Mar 23
Acer Therapeutics / Jason Amello ownership change
4:21pm
8-K
ct395 dev3bfxziidbis
15 Mar 23
Other Events
9:00am
SC 13G/A
h4byah vprftdkeo8z
14 Feb 23
Acer Therapeutics / Nantahala Capital Management ownership change
4:56pm
8-K
gapl1h
13 Feb 23
Topline trial results expected mid-March 2023
9:00am
424B2
u8rom3
7 Feb 23
Prospectus for primary offering
4:08pm
8-K
dhwbpqssreomxh8ovq7
7 Feb 23
Other Events
4:01pm
8-K
3qkm1 gwziz
1 Feb 23
Regulation FD Disclosure
4:03pm
8-K
992pd2kdy
31 Jan 23
Entry into a Material Definitive Agreement
9:25am
8-K
xai35k7j c9xna9
9 Jan 23
Acer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones
9:00am
8-K
tsmu8tbc stu
5 Jan 23
Regulation FD Disclosure
9:00am
8-K
z4zhgjx8
3 Jan 23
Entry into a Material Definitive Agreement
9:00am
8-K
3fhh4p47fu
29 Dec 22
Other Events
9:00am
8-K
jp5a 526wgbdwccuhx
27 Dec 22
New FDA-approved formulation for patients living with urea cycle disorders
8:33am